Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 SYBX | Healthcare | $1.10 | 14.00 | $13.17M | -5.99 | ― | ― |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SYBX | Synlogic | 1.10 | -0.62 | -36.01% |
| Name | Price | % Change | |
|---|---|---|---|
| SYBX | $1.10 | -36.01% |
Caldera Therapeutics announced new data from single- and multiple-dose cohorts of its Phase 1a healthy volunteer trial of CLD-423, an investigational bispecific antibody targeting IL-23p19 and TL1A for the treatment
Caldera Therapeutics announced the appointments of Michelle Doig as CFO and Lee Giguere, J.D., as CLO. Prior to joining Caldera as CFO, Ms. Doig served as Partner and Head of
Synlogic ( ($SYBX) ) has issued an announcement. On July 28, 2026, Synlogic and Caldera entered a definitive all-stock merger agreement that will see both companies become wholly owned subsidiaries
Synlogic (SYBX) and Caldera Therapeutics entered into a definitive merger agreement to combine in an all-stock transaction. The combination will be accomplished by both companies becoming wholly-owned subsidiaries of a
The latest update is out from Synlogic ( ($SYBX) ). On November 21, 2025, Synlogic received a notice from Nasdaq’s Listing Qualifications Department stating that, based on its review of
Synlogic ( ($SYBX) ) has provided an update. On December 15, 2025, Synlogic held its Annual Meeting where 87.97% of the outstanding shares were represented. During the meeting, James Flynn
Synlogic ( ($SYBX) ) has provided an announcement. On November 21, 2025, Synlogic, Inc. received a notice from the Nasdaq Stock Market’s Listing Qualifications Department, which expressed concerns about the
16:01 EDT Synlogic (SYBX) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on
Synlogic Inc ( ($SYBX) ) has released its Q2 earnings. Here is a breakdown of the information Synlogic Inc presented to its investors. Synlogic Inc. is a biopharmaceutical company specializing
Synlogic Inc ( ($SYBX) ) has released its Q1 earnings. Here is a breakdown of the information Synlogic Inc presented to its investors. Synlogic Inc., a biopharmaceutical company, focuses on
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
